Bas van Driel, CEO Bas van Driel, CEO
Bas van Driel, CEO

‘We care’ mantra spurs DFE Pharma’s drive towards excipient excellence

Company offers a comprehensive portfolio for oral solid dose and dry powder formulations, ranging from starch, lactose and microcrystalline cellulose to inhalants and superdisintegrant

Topic |   Germany Business Report 2017
Bas van Driel, CEO Bas van Driel, CEO
Bas van Driel, CEO
READ FULL ARTICLE